Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 15 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (7)
P 1 (1)
P 2 (2)
P 4 (2)

Trial Status

Completed4
Recruiting4
Enrolling By Invitation3
Not Yet Recruiting2
Active Not Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07370441Phase 4Enrolling By Invitation

Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients

NCT07539428Not ApplicableEnrolling By InvitationPrimary

Peritoneal Dialysis (PD) Specialized LLM for PD Management

NCT06642597Not ApplicableRecruitingPrimary

STarting incrEmental Prescription of Peritoneal Dialysis

NCT07059962Recruiting

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

NCT07477210Active Not RecruitingPrimary

Examine the Epidemiology and Outcomes of Transitions From PD-to-HD in Canada

NCT07157397Not ApplicableRecruiting

Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients

NCT07437677Not Yet RecruitingPrimary

A Survey for Patients and Caregivers Aiming to Understand and Improve the Care of Patients at High Risk of Transfer From Peritoneal Dialysis to Hemodialysis:

NCT07338435Not ApplicableActive Not Recruiting

"Residual Kidney Function and Oxidative Stress in Incremental vs Standard Peritoneal Dialysis (2 Mexican Centers)"

NCT07326085Not ApplicableRecruitingPrimary

Pilot Study to Evaluate the Feasibility, Adherence and Acceptance of the MiDiálisis Platform for Patients on PD

NCT07113587Phase 2Completed

Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis

NCT07113574Phase 2Completed

Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis

NCT07098923Not ApplicableCompleted

The Effect of Exercise on Blood Pressure Variability on Peritoneal Dialysis Patients

NCT06830941Phase 4Not Yet Recruiting

Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients

NCT06738550Not ApplicableEnrolling By Invitation

Effect of Agave Inulin on Constipation and Quality of Life in Peritoneal Dialysis Patients.

NCT02909153Phase 1CompletedPrimary

Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis

Showing all 15 trials

Research Network

Activity Timeline